Biotecnofe Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 2

Biotecnofe General Information

Description

Developer of biotechnology products intended to serve the veterinary industry in sustainably and qualitatively feeding the planet. The company specializes in the research, development, and production of biotherapeutics, helping clients improve animal health and productivity.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • Route 168 Pje.el Pozo Ptlc
  • Santa Fe, 3000
  • Argentina
Primary Industry
Other Pharmaceuticals and Biotechnology
Corporate Office
  • Route 168 Pje.el Pozo Ptlc
  • Santa Fe, 3000
  • Argentina

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biotecnofe Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biotecnofe‘s full profile, request access.

Request a free trial

Biotecnofe Patents

Biotecnofe Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020418449-A1 Method for obtaining a mammalian cell line that expresses a recombinant equine chorionic gonadotropin (recg), the recombinant cell lines producing recg, large-scale recg production method, recg, formulations containing recg, nucleic acids encoding for recg and uses Active 30-Dec-2019
AU-2020418449-B2 Method for obtaining a mammalian cell line that expresses a recombinant equine chorionic gonadotropin (recg), the recombinant cell lines producing recg, large-scale recg production method, recg, formulations containing recg, nucleic acids encoding for recg and uses Active 30-Dec-2019
EP-4085071-A1 Method for obtaining a mammalian cell line that expresses a recombinant equine chorionic gonadotropin (recg), the recombinant cell lines producing recg, large-scale recg production method, recg, formulations containing recg, nucleic acids encoding for recg and uses Pending 30-Dec-2019
US-20230242608-A1 Method for obtaining a mammalian cell line that expresses a recombinant equine chorionic gonadotropin (recg), the recombinant cell lines producing recg, large-scale recg production method, recg, formulations containing recg, nucleic acids encoding for recg and uses Pending 30-Dec-2019
WO-2021136736-A1 Method for obtaining a mammalian cell line that expresses a recombinant equine chorionic gonadotropin (recg), the recombinant cell lines producing recg, large-scale recg production method, recg, formulations containing recg, nucleic acids encoding for recg and uses Inactive 30-Dec-2019 C12N15/86
To view Biotecnofe’s complete patent history, request access »

Biotecnofe Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Biotecnofe‘s full profile, request access.

Request a free trial

Biotecnofe FAQs

  • When was Biotecnofe founded?

    Biotecnofe was founded in 2018.

  • Where is Biotecnofe headquartered?

    Biotecnofe is headquartered in Santa Fe, Argentina.

  • What industry is Biotecnofe in?

    Biotecnofe’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Biotecnofe a private or public company?

    Biotecnofe is a Private company.

  • What is Biotecnofe’s current revenue?

    The current revenue for Biotecnofe is .

  • Who are Biotecnofe’s investors?

    Parque Tecnologico Litoral Centro has invested in Biotecnofe.

  • When was Biotecnofe acquired?

    Biotecnofe was acquired on 05-Dec-2022.

  • Who acquired Biotecnofe?

    Biotecnofe was acquired by Ceva Santé Animale.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process